Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: December 5, 2021

DrugPatentWatch Database Preview

Patent: 4,273,703

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 4,273,703
Title: Interferon product and process for its preparation
Abstract:Exogenic porcine interferon for administration in human beings. The porcine interferon shows antiviral protecting activity on cultured human cells and is substantially free of any immunoelectrophoresis bands which are not identical or partially identical with bands in human leucocyte interferon or human agammaserum. A process for preparing the porcine interferon by harvesting, isolating and, if desired, priming porcine leucocytes, treating them with an interferon inductor and incubating them and obtaining the interferon formed, the process being characterized in using, as added protein source in any of the said stages, a source which is substantially free of immunoelectrophoresis band which are not identical or partially identical with bands in human agammaserum.
Inventor(s): Osther; Kurt B. (Naerum, DK), Jensen; Werner K. (Roskilde, DK)
Assignee: Ess-Food Eksport-Svineslagteriernes Salgsforening (Copenhagen, DK)
Application Number:05/955,389
Patent Claims:see list of patent claims

Details for Patent 4,273,703

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 1942-10-21 ⤷  Try it Free 1998-06-16
Baxalta Us Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 1954-03-03 ⤷  Try it Free 1998-06-16
Csl Behring Ag ALBURX albumin (human) Injection 102366 1976-07-23 ⤷  Try it Free 1998-06-16
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.